tiprankstipranks
Trending News
More News >
Kose Corporation (JP:4922)
:4922
Advertisement

Kose (4922) AI Stock Analysis

Compare
2 Followers

Top Page

JP:4922

Kose

(OTC:4922)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 4o)
Rating:62Neutral
Price Target:
Â¥6,335.00
â–²(6.01% Upside)
Kose's overall stock score is driven by strong financial stability and positive technical indicators. However, high valuation and declining net profitability weigh down the score. Addressing cash flow challenges and improving net margins are crucial for future growth.

Kose (4922) vs. iShares MSCI Japan ETF (EWJ)

Kose Business Overview & Revenue Model

Company DescriptionKOSÉ Corporation, together with its subsidiaries, manufactures, markets, and sells cosmetics primarily in Asia, the United States, and internationally. It offers cleansing, facial wash, toner, emulsion, cream, gel/serum, pack mask, lip care, and massage products. The company also provides sunscreen, fragrance, makeup goods, hair products, beauty supplements, and other cosmetics. It offers its cosmetics under the DECORTÉ, JILLSTUART, ADDICTION, INFINITY, Awake, tarte, ALBION, MIYABI, Paul & Joe, IGNIS, Elegance, INFIORE, ANNA SUI, Predia, iMPREA, X-Barrier, ACNEO, ASTALUXE, MAIHADA, LECHÉRI, ESPRIQUE, SEKKISEI, ONE BY KOSÉ, Visée, FASIO, NAILHOLIC, BIOLISS, Magnifique, CLEAR TURN, BIOLISS, Je l'aime, softymo, SUNCUT, MAKE KEEP MIST, and GRACE ONE brands. It offers its products through specialty cosmetic stores, department stores, cosmetics stores, mass retailers, drugstores, convenience stores, and other retail outlets, as well as e-commerce. KOSÉ Corporation was founded in 1946 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyKose Corporation generates revenue primarily through the sale of its cosmetics and skincare products. The company's key revenue streams include domestic sales in Japan and international sales across Asia, North America, and Europe. Kose utilizes a multi-channel distribution approach, selling products through department stores, specialty cosmetic shops, and online platforms. Strategic partnerships and collaborations with other brands and retailers also play a significant role in expanding its market reach and driving sales. Additionally, Kose invests in research and development to continuously innovate and enhance its product offerings, which helps maintain its competitive edge in the global beauty industry.

Kose Financial Statement Overview

Summary
Kose shows strong revenue growth and gross profitability with a robust balance sheet and minimal leverage. However, declining net profitability and challenges in free cash flow sustainability are concerns.
Income Statement
75
Positive
Kose experienced a moderate revenue growth of 7.42% from 2023 to 2024, but this was lower compared to its growth in previous years. The gross profit margin for 2024 was 68.95%, indicating strong profitability in production. However, the net profit margin decreased to 2.33% in 2024 from 3.88% in 2023, signaling a decline in net profitability. The EBITDA margin was 9.15%, showing stable operational efficiency, though it has decreased compared to previous periods. Overall, Kose's income statement reflects strong revenue growth and gross profitability, but declining net profitability poses a risk.
Balance Sheet
80
Positive
Kose's balance sheet remains robust with an equity ratio of 71.05% in 2024, indicating strong financial stability and low reliance on debt. The debt-to-equity ratio is very low at 0.04, showing minimal leverage. The return on equity was 2.76% for 2024, indicating a decrease in profitability from equity compared to previous years. Kose's financial position is stable, with excellent equity health and low debt levels, though there's room for improvement in equity returns.
Cash Flow
60
Neutral
The cash flow statement shows a significant decline in free cash flow from 2023 to 2024, turning negative at -2.67 billion, reflecting potential issues in cash generation. The operating cash flow to net income ratio is strong at 2.45, indicating good cash generation from operations relative to net income. However, the free cash flow to net income ratio is negative, highlighting potential cash flow challenges. Overall, Kose's cash flow statement indicates strong operational cash flows but highlights concerns over free cash flow sustainability.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue324.17B322.76B300.41B289.14B299.98B279.39B
Gross Profit223.08B222.57B211.20B205.51B204.15B201.92B
EBITDA28.03B29.55B30.10B38.63B39.70B30.68B
Net Income5.86B7.51B11.66B18.77B17.79B11.99B
Balance Sheet
Total Assets377.27B383.12B371.66B359.60B320.02B308.39B
Cash, Cash Equivalents and Short-Term Investments98.56B113.97B132.85B116.53B105.28B103.39B
Total Debt10.39B11.22B10.21B9.98B1.42B8.53B
Total Liabilities88.67B92.49B88.62B84.25B65.75B67.09B
Stockholders Equity270.38B272.30B266.16B258.99B238.36B225.50B
Cash Flow
Free Cash Flow0.00-2.67B24.92B13.16B12.99B12.54B
Operating Cash Flow0.0018.38B30.44B20.26B17.80B23.28B
Investing Cash Flow0.00-8.93B-11.23B-6.31B-4.72B-5.85B
Financing Cash Flow0.00-8.68B-9.68B-7.31B-14.30B-7.36B

Kose Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5976.00
Price Trends
50DMA
5814.30
Positive
100DMA
5762.87
Positive
200DMA
6101.40
Negative
Market Momentum
MACD
38.11
Negative
RSI
55.38
Neutral
STOCH
42.73
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4922, the sentiment is Positive. The current price of 5976 is above the 20-day moving average (MA) of 5842.80, above the 50-day MA of 5814.30, and below the 200-day MA of 6101.40, indicating a neutral trend. The MACD of 38.11 indicates Negative momentum. The RSI at 55.38 is Neutral, neither overbought nor oversold. The STOCH value of 42.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4922.

Kose Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
585.27B16.9011.92%1.43%15.90%13.60%
70
Outperform
162.41B21.2015.26%4.73%-1.63%1.81%
69
Neutral
422.71B20.637.05%1.85%1.29%4.72%
68
Neutral
299.65B46.625.63%3.87%-0.89%-34.14%
62
Neutral
$334.88B112.201.11%2.34%2.82%-79.45%
55
Neutral
1.03T-793.23-0.21%1.95%-3.60%-112.93%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4922
Kose
5,976.00
-3,303.67
-35.60%
LIOPF
Lion
10.50
>-0.01
-0.10%
PORBF
Pola Orbis Holdings
8.88
-1.25
-12.34%
RPHCF
Rohto Pharmaceutical Co
14.72
-9.66
-39.62%
JP:4911
Shiseido Company,Limited
2,553.00
-1,386.75
-35.20%
JP:4928
Noevir Holdings Co., Ltd.
4,730.00
-520.00
-9.90%

Kose Corporate Events

KOSÉ Corporation Reports Decline in Profits Despite Increased Sales
Aug 7, 2025

KOSÉ Corporation reported its financial results for the second quarter of fiscal year 2025, showing a slight increase in net sales by 0.9% compared to the previous year. However, there was a significant decline in operating profit, ordinary profit, and profit attributable to owners of the parent, with decreases of 17.7%, 49.1%, and 38.9% respectively. The company’s comprehensive income also dropped by 86.7%. Despite these declines, the equity ratio improved to 73.3%, indicating a stronger financial position. The company maintained its dividend forecast and did not revise its consolidated forecast for the full year of 2025.

The most recent analyst rating on (JP:4922) stock is a Hold with a Yen7000.00 price target. To see the full list of analyst forecasts on Kose stock, see the JP:4922 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 26, 2025